EC Pulmonology and Respiratory Medicine

Opinion Volume 12 Issue 2 - 2023

Distortions of the Modern Ideology of Acute Pneumonia

Igor Klepikov*

MD, Professor, Retired, Renton, WA, USA

*Corresponding Author: Igor Klepikov, MD, Professor, Retired, Renton, WA, USA.
Received: February 07, 2023; Published:February 28, 2023



The successful result of scientific research and the effective solution of practical problems completely depend on the correct definition of their goals. This is an axiom of medical science and practice, without which it is impossible to count on the success of any endeavors. The reliability and verifiability of this rule only increases the feeling of deep disappointment and annoyance when it comes to widespread and persistent attempts to solve the problem of acute pneumonia (AP) in the same way that led it to a state of modern stagnation. The professional stereotype of ideas about the origin and development of AP, which has developed over the past few decades, continues to persistently consider only selective causes of this disease as the basis for a strategic solution to the problem.

  1. I Klepikov. “The Didactics of Acute Lung Inflammation”. Cambridge Scholars Publishing (2022): 320.
  2. Gram C. "Über die isolierte Färbung der Schizomyceten in Schnitt- und Trocken-präparaten". Fortschritte der Medizin6 (1884): 185-189.
  3. Wikipedia.
  4. Blood pressure.
  5. "Normal Hemodynamic Parameters – Adult". Edwards Lifesciences LLC. Archived from the original (2010).
  6. Olivia Vynn. “Cardiology secrets. Chapter Adair Edition: 2, illustrated Published by Elsevier Health Sciences 41 (2001): 210.
  7. Schwiegk H. “Der Lungenentlastungsreflex”. Pflügers Archiv - European Journal of Physiology 236 (1935): 206-219.
  8. Thillai M., et al. “Functional respiratory imaging identifies redistribution of pulmonary blood flow in patients with COVID-19”. Thorax 76 (2021): 182-184.
  9. W Dierckx., et al. “CT-derived measurements of pulmonary blood volume in small vessels and the need for supplemental oxygen in COVID-19 patients”. Journal of Applied Physiology6 (2022): 1295-1299.
  10. Klepikov Igor. “The Effect of Intravenous Infusion on the Dynamics of Acute Pneumonia”. EC Pulmonology and Respiratory Medicine1 (2017): 15-20.
  11. Singer M., et al. “The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)”. The Journal of the American Medical Association8 (2016): 801-810.
  12. Antimicrobial resistance (2021).
  13. Fleming A. "The Nobel Prize in Physiology or Medicine 1945 -Penicillin: Nobel Lecture" (1945).
  14. Abraham EP and Chain E. "An enzyme from bacteria able to destroy penicillin". Nature3713 (1940): 837.
  15. B Beović., et al. “Antibiotic use in patients with COVID-19: a ‘snapshot’ Infectious Diseases International Research Initiative (ID-IRI) survey”. Journal of Antimicrobial Chemotherapy (2020): 326.
  16. Kim D., et al. “Rates of co-infection between SARS-CoV-2 and other respiratory pathogens”. The Journal of the American Medical Association 323 (2020): 2085-2086.
  17. Rawson TM., et al. “Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing”. Clinical Infectious Diseases (2020): ciaa 530.
  18. BD Huttner., et al. “COVID-19: don't neglect antimicrobial stewardship principles!”. Clinical Microbiology and Infection7 (2020): 808-810.
  19. Lee J Quinton., et al. “Integrative Physiology of Pneumonia”. Physiological Reviews3 (2018): 1417-1464.
  20. Carvalho G., et al. “Antibiotic resilience: a necessary concept to complement antibiotic resistance?". Proceedings Biological Sciences 1916 (2019): 20192408.
  21. Lucien Mentor Ali Ber., et al. “Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings". International Journal of Infectious Diseases 104 (2021): 250-254.
  22. C Heneghan., et al. “Differentiating viral from bacterial pneumonia. The Centre for Evidence-Based Medicine”. Evidence Service to support the COVID-19 response. University of Oxford (2020).
  23. Kamat IS., et al. “Procalcitonin to Distinguish Viral From Bacterial Pneumonia: A Systematic Review and Meta-analysis”. Clinical Infectious Diseases3 (2020): 538-542.
  24. Kim D., et al. “Rates of co-infection between SARS-CoV-2 and other respiratory pathogens”. The Journal of the American Medical Association 323 (2020): 2085-2086.

Igor Klepikov. “Distortions of the Modern Ideology of Acute Pneumonia”. EC Pulmonology and Respiratory Medicine  12.2 (2023): 23-27.